22. Prevalence and predictors of persistent postpartum hypertension among women with hypertensive disorders of pregnancy at the National Hospital of Obstetrics and Gynecology
Main Article Content
Abstract
The aim of this study was to determine the prevalence and identify the predictors of persistent hypertension at three months after delivery among women with hypertensive disorders of pregnancy (HDP) at the National Hospital of Obstetrics and Gynecology (NHOG). A prospective cohort study was conducted on 360 women with HDP who were delivered at the NHOG from January 2023 to November 2023. Participants were enrolled within 24 hours of delivery and followed up to three months after delivery. Of the 360 participants initially enrolled, 301 were successfully followed up to 3 months after delivery (follow-up rate 83.6%). Among women with HDP, 7.6% experienced persistent hypertension at three months after delivery. On bivariate logistic regression, variables such as maternal age, gestational age at delivery, serum creatinine level, hypertension at seven days postpartum, and hypertension at six weeks postpartum were found to be associated with persistent postpartum hypertension. Further analysis at multivariate level revealed that maternal age of 35 years or older, elevated serum creatinine level (≥ 1.1 mg/dl), and hypertension at six weeks after delivery were independent predictors of persistent postpartum hypertension at three months postpartum. Our study showed that approximately 1 in 13 women with HDP at the NHOG remained hypertensive at three months after delivery. There is a need for identifying high-risk women and providing timely interventions to control postpartum blood pressure and reduce the risk of future cardiovascular complications following HDP.
Article Details
Keywords
persistent postpartum hypertension, hypertensive disorders of pregnancy, predictors
References
2. von Dadelszen P, Magee LA. Preventing deaths due to the hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016;36:83-102. doi:10.1016/j.bpobgyn.2016.05.005
3. Ying W, Catov JM, Ouyang P. Hypertensive Disorders of Pregnancy and Future Maternal Cardiovascular Risk. J Am Heart Assoc Cardiovasc Cerebrovasc Dis. 2018;7(17):e009382. doi:10.1161/JAHA.118.009382
4. Giorgione V, Ridder A, Kalafat E, et al. Incidence of postpartum hypertension within 2 years of a pregnancy complicated by pre-eclampsia: a systematic review and meta-analysis. BJOG Int J Obstet Gynaecol. 2021;128(3):495-503. doi:10.1111/1471-0528.16545
5. Lugobe HM, Kayondo M, Mceniery CM, et al. Persistent hypertension at 3 months postpartum among women with hypertensive disorders of pregnancy at a tertiary hospital in Southwestern Uganda. AJOG Glob Rep. 2023;3(1):100163. doi:10.1016/j.xagr.2023.100163
6. Martillotti G, Ditisheim A, Burnier M, et al. Increased salt sensitivity of ambulatory blood pressure in women with a history of severe preeclampsia. Hypertens Dallas Tex 1979. 2013;62(4):802-808. doi:10.1161/HYPERTENSIONAHA.113.01916
7. Chen KH, Chen LR. Provoking factors for postpartum chronic hypertension in women with preceding gestational hypertension/preeclampsia: A longitudinal cohort study of 22,798 pregnancies. Int J Med Sci. 2020;17(4):543-548. doi:10.7150/ijms.39432
8. Sibai BM. Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gynecol. 2012;206(6):470-475. doi:10.1016/j.ajog.2011.09.002
9. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183(1):S1-S22.
10. Podymow T, August P. Postpartum course of gestational hypertension and preeclampsia. Hypertens Pregnancy. 2010;29(3):294-300. doi:10.3109/10641950902777747
11. ACOG Committee Opinion No. 736: Optimizing Postpartum Care. Obstet Gynecol. 2018;131(5):e140-e150. doi:10.1097/AOG.0000000000002633
12. Hirshberg A, Downes K, Srinivas S. Comparing standard office-based follow-up with text-based remote monitoring in the management of postpartum hypertension: a randomised clinical trial. BMJ Qual Saf. 2018;27(11):871-877. doi:10.1136/bmjqs-2018-007837
13. Steele DW, Adam GP, Saldanha IJ, et al. Postpartum Home Blood Pressure Monitoring: A Systematic Review. Obstet Gynecol. 2023;142(2):285-295. doi:10.1097/AOG.0000000000005270
14. Weinfeld JM, Hart KM, Vargas JD. Home Blood Pressure Monitoring. Am Fam Physician. 2021;104(2):237-243.
15. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237. doi:10.1097/AOG.0000000000003891
16. Fathy HM, Makled AK, Sabaa HA, et al. Incidence and Risk Factors That Predict Chronic Hypertension after Delivery in Women with Hypertensive Disorders of Pregnancy. Egypt J Hosp Med. 2017;69(2):1901-1907. doi:10.12816/0040620
17. Babah OA, Olaleye O, Afolabi BB. Postpartum Sequelae of the Hypertensive Diseases of Pregnancy: A Pilot Study. Niger Med J J Niger Med Assoc. 2018;59(1):1-6. doi:10.4103/nmj.NMJ_101_18
18. Levine LD, Nkonde-Price C, Limaye M, et al. Factors associated with postpartum follow-up and persistent hypertension among women with severe preeclampsia. J Perinatol Off J Calif Perinat Assoc. 2016;36(12):1079-1082. doi:10.1038/jp.2016.137
19. Fajardo Tornes Y, Nápoles Mèndez D, Alvarez Aliaga A, et al. Predictors of Postpartum Persisting Hypertension Among Women with Preeclampsia Admitted at Carlos Manuel de Cèspedes Teaching Hospital, Cuba. Int J Womens Health. 2020;12:765-771. doi:10.2147/IJWH.S263718
20. Ndayambagye EB, Nakalembe M, Kaye DK. Factors associated with persistent hypertension after puerperium among women with pre-eclampsia/eclampsia in Mulago hospital, Uganda. BMC Pregnancy Childbirth. 2010;10(1):12. doi:10.1186/1471-2393-10-12
21. Chen KH, Chen LR. Provoking factors for postpartum chronic hypertension in women with preceding gestational hypertension/preeclampsia: A longitudinal cohort study of 22,798 pregnancies. Int J Med Sci. 2020;17(4):543-548. doi:10.7150/ijms.39432
22. Ishaku SM, Jamilu T, Innocent AP, et al. Persistent Hypertension Up to One Year Postpartum among Women with Hypertensive Disorders in Pregnancy in a Low-Resource Setting: A Prospective Cohort Study. Glob Heart. 2021;16(1):62. doi:10.5334/gh.854
23. El Assar M, Angulo J, Vallejo S, et al. Mechanisms Involved in the Aging-Induced Vascular Dysfunction. Front Physiol. 2012;3:132. doi:10.3389/fphys.2012.00132
24. Cooke CLM, Davidge ST. Advanced maternal age and the impact on maternal and offspring cardiovascular health. Am J Physiol-Heart Circ Physiol. 2019;317(2):H387-H394. doi:10.1152/ajpheart.00045.2019
25. Lean SC, Heazell AEP, Dilworth MR, et al. Placental Dysfunction Underlies Increased Risk of Fetal Growth Restriction and Stillbirth in Advanced Maternal Age Women. Sci Rep. 2017;7(1):9677. doi:10.1038/s41598-017-09814-w
26. Clark BA, Halvorson L, Sachs B, et al. Plasma endothelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment. Am J Obstet Gynecol. 1992;166(3):962-968. doi:10.1016/0002-9378(92)91372-h
27. WHO. Executive summary. In: WHO Recommendations on Postnatal Care of the Mother and Newborn. World Health Organization; 2013. Accessed December 24, 2023. https://www.ncbi.nlm.nih.gov/books/NBK190090/
28. Brown MA, Magee LA, Kenny LC, et al. Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. Hypertens Dallas Tex 1979. 2018;72(1):24-43. doi:10.1161/HYPERTENSIONAHA.117.10803